PlainRecalls
FDA Drug Moderate Class II Terminated

Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02

Reported: November 21, 2018 Initiated: September 27, 2018 #D-0244-2019

Product Description

Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02

Reason for Recall

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
1,362 vials
Distribution
Product was distributed throughout the United States, including Hawaii and Puerto Rico.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02. Recalled by Teva Pharmaceuticals USA. Units affected: 1,362 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on November 21, 2018. Severity: Moderate. Recall number: D-0244-2019.